Updated meta-analysis of the NFκB1-94ins/delattg promoter polymorphism and cancer risk based on 19 case-control studies

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 10, 2011, Pages 2479-2484

  Wang, Xiefeng ^a   Lu, Pi ^a   Xu, Lu ^a   Xu, Yanjie ^a   Shi, Zhumei ^a   Xu, Jiali ^a   Wang, Yingyi ^a   Zhang, Junxia ^a,b   Wang, Xirui ^a   Cao, Lei ^a   Liu, Ning ^a   Yin, Yongmei ^a   You, Yongping ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Analysis; Carcinogenesis; Genetic polymorphisms; Meta; Nfkb1

Indexed keywords

EID: 84863283650     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Andersen V, Christensen J, Overvad K, Tjonneland A, Vogel U (2010). Polymorphisms in NFkB, PXR, LXR and risk of colorectal cancer in a prospective study of Danes. BMC Cancer, 10, 484.
2. Baldwin AS Jr (1996). The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol, 14, 649-83.
3. Baldwin AS Jr (2001). Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest, 107, 3-6.
4. Balkwill F, Mantovani A (2001). Inflammation and cancer: back to Virchow? Lancet, 357, 539-45.
5. Bu H, Rosdahl I, Sun XF, Zhang H (2007). Importance of polymorphisms in NF-kappaB1 and NF-kappaBIalpha genes for melanoma risk, clinicopathological features and tumor progression in Swedish melanoma patients. J Cancer Res Clin Oncol, 133, 859-66.
6. Burnik FS, Yalcin S (2009). NFkB1-94 insertion/deletion ATTG polymorphism in gastroenteropancreatic neuroendocrine tumors. Chemotherapy, 55, 381-5.
7. Chen F, Castranova V, Shi X, Demers LM (1999). New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. Clin Chem, 45, 7-17.
8. Coussens LM, Werb Z (2002). Inflammation and cancer. Nature, 420, 860-7.
9. Fan Y, Yu W, Ye P, et al (2011). NFkB1 insertion/deletion promoter polymorphism increases the risk of advanced ovarian cancer in a Chinese population. DNA Cell Biol, 30, 241-5.
10. Geddes M, Balzi D, Buiatti E, Khlat M, Parkin D (1991). Cancer in Italian migrants. Cancer Causes Control, 2, 133-40.
11. He Y, Zhang H, Yin J, et al (2009). IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C. Carcinogenesis, 30, 1916-22.
12. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K (2002). A comprehensive review of genetic association studies. Genet Med, 4, 45-61.
13. Iscovich J, Howe GR (1998). Cancer incidence patterns (1972-91) among migrants from the Soviet Union to Israel. Cancer Causes Control, 9, 29-36.
14. Karban AS, Okazaki T, Panhuysen CI, et al (2004). Functional annotation of a novel NFkB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet, 13, 35-45.
15. Karin M, Delhase M (2000). The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin Immunol, 12, 85-98.
16. Le Beau MM, Ito C, Cogswell P, et al (1992). Chromosomal localization of the genes encoding the p50/p105 subunits of NF-kappa B (NFKB2) and the I kappa B/MAD-3 (NFKBI) inhibitor of NF-kappa B to 4q24 and 14q13, respectively. Genomics, 14, 529-31.
17. Lewander A, Butchi AK, Gao J, et al (2007). Polymorphism in the promoter region of the NFkB1 gene increases the risk of sporadic colorectal cancer in Swedish but not in Chinese populations. Scand J Gastroenterol, 42, 1332-8.
18. Lin SC, Liu CJ, Yeh WI, et al (2006). Functional polymorphism in NFkB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers. Cancer Lett, 243, 47-54.
19. Lo SS, Chen JH, Wu CW, Lui WY (2009). Functional polymorphism of NFkB1 promoter may correlate to the susceptibility of gastric cancer in aged patients. Surgery, 145, 280-5.
20. Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
21. Maskarinec G, Noh JJ (2004). The effect of migration on cancer incidence among Japanese in Hawaii. Ethn Dis, 14, 431-9.
22. Mathew S, Murty VV, Dalla-Favera R, Chaganti RS (1993). Chromosomal localization of genes encoding the transcription factors, c-rel, NF-kappa Bp50, NF-kappa Bp65, and lyt-10 by fluorescence in situ hybridization. Oncogene, 8, 191-3.
23. Pahl HL (1999). Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene, 18, 6853-66.
24. Riemann K, Becker L, Struwe H, et al (2006). No association of the NFkB1 insertion/deletion promoter polymorphism with survival in colorectal and renal cell carcinoma as well as disease progression in B-cell chronic lymphocytic leukemia. Pharmacogenet Genomics, 16, 783-8.
25. Riemann K, Becker L, Struwe H, et al (2007). Insertion/deletion polymorphism in the promoter of NFkB1 as a potential molecular marker for the risk of recurrence in superficial bladder cancer. Int J Clin Pharmacol Ther, 45, 423-30.
26. Samsami Dehaghani A, Shahriary K, Kashef MA, et al (2009). Interleukin-18 gene promoter and serum level in women with ovarian cancer. Mol Biol Rep, 36, 2393-7.
27. Shacter E, Weitzman SA (2002). Chronic inflammation and cancer. Oncology, 16, 217-26, 229; discussion 230-2.
28. Song S, Chen D, Lu J, et al (2011). NFkappaB1 and NFkappaBIA polymorphisms are associated with increased risk for sporadic colorectal cancer in a southern Chinese population. PLoS One, 6, e21726.
29. Tang T, Cui S, Deng X, et al (2010). Insertion/deletion polymorphism in the promoter region of NFkB1 gene increases susceptibility for superficial bladder cancer in Chinese. DNA Cell Biol, 29, 9-12.
30. Zhang L, Du C, Guo X, et al (2010). Interleukin-8-251A/T polymorphism and Helicobacter pylori infection influence risk for the development of gastric cardiac adenocarcinoma in a high-incidence area of China. Mol Biol Rep, 37, 3983-9.
31. Zhang P, Wei Q, Li X, et al (2009). A functional insertion/deletion polymorphism in the promoter region of the NFkB1 gene increases susceptibility for prostate cancer. Cancer Genet Cytogenet, 191, 73-7.
32. Zhou B, Rao L, Li Y, et al (2009). A functional insertion/deletion polymorphism in the promoter region of NFkB1 gene increases susceptibility for nasopharyngeal carcinoma. Cancer Lett, 275, 72-6.
33. Zhou B, Qie M, Wang Y, et al (2010). Relationship between NFkB1-94 insertion/deletion ATTG polymorphism and susceptibility of cervical squamous cell carcinoma risk. Ann Oncol, 21, 506-11.
34. Zou YF, Yuan FL, Feng XL, et al (2011). Association between NFkB1-94ins/delATTG promoter polymorphism and cancer risk: a meta-analysis. Cancer Invest, 29, 78-85.